I still think the CEO needs to go!
To the meeting!![]()
- Forums
- ASX - By Stock
- MSB
- Ann: Meeting Requested with FDA on Revascor Accelerated Approval
MSB
mesoblast limited
Add to My Watchlist
0.00%
!
$1.83

Ann: Meeting Requested with FDA on Revascor Accelerated Approval, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.83 |
Change
0.000(0.00%) |
Mkt cap ! $2.331B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 122 | $2.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.71 | 1203 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 122 | 1.995 |
7 | 4599 | 1.935 |
1 | 6251 | 1.860 |
2 | 666 | 1.835 |
4 | 884 | 1.830 |
Price($) | Vol. | No. |
---|---|---|
1.715 | 980 | 3 |
1.735 | 11390 | 2 |
1.755 | 1625 | 3 |
1.765 | 1 | 1 |
1.780 | 6520 | 3 |
Last trade - 10.04am 18/06/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online